# Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter System 3 ("RETRIEVE 3")

> **NCT01120522** · PHASE3 · COMPLETED · sponsor: **Crux Biomedical** · enrollment: 17 (actual)

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DEVICE:** Inferior Vena Cava Filter

## Key facts

- **NCT ID:** NCT01120522
- **Lead sponsor:** Crux Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-06
- **Final completion:** 2012-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2014-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01120522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01120522, "Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter System 3 ("RETRIEVE 3")". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01120522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*